The global facial aesthetics market was valued at $6,234.5 million in 2021, and is projected to reach $25,764.5 million by 2031, registering a CAGR of 15.5% from 2022 to 2031. Facial aesthetics is a non-surgical procedure that revitalizes the skin. It is a facial rejuvenation treatment that reduces signs of ageing on the face. Facial aesthetic procedures provide more youthful and radiant appearance. The treatment offers facial contouring, defines certain facial features and it can soften wrinkles. Non-surgical aesthetic treatment helps in lifting up the confidence of people by improving the smile or skin in and masking the effect of age in less complicated way. Facial aesthetic procedure helps reduce and eliminate facial lines and wrinkles, it can treat scar and blemishes, it removes thicker and uneven skin layer and has many other benefits. In addition, non-surgical aesthetic procedures ensure quicker recovery and lesser pain than traditional surgical cosmetic procedures.
The facial aesthetics market is driven by rise in shift of customers toward minimally invasive and non-invasive procedures, increase in number of non-surgical aesthetic procedures such as facial contouring, Botox, injections, facial fillers and other, rise in awareness regarding skin health, and surge in expenditure on human healthcare services boosts growth of the market. According to a report by the American society of plastic surgeons (ASPS), in 2020, it was reported that around 16 million cosmetic procedures are conducted, globally. As per the same source, it was also reported that consumers spent approximately $20 billion on facial aesthetics procedures globally for total consumers. Moreover, according to a report shared by American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) in February 2022, total number of surgical and non-surgical procedures was 1.4 million in 2021, and have increased by 40% than 2020.
In addition, rise in number of botulinum toxin procedure which is also known as Botox injection anticipated to fuel the market growth. For instance, according to a report by Statista, published in 2021, botulinum toxin is the highest non-surgical procedure performed worldwide. Approximately 2.6 million botulinum toxin procedures were performed in 2020 across the globe. Moreover, rise in self-awareness among people regarding aesthetic appearance anticipated to propel the growth of facial aesthetics market. However, side effects associated with facial aesthetic procedures and high cost of procedures are anticipated to hinder the market growth during the forecast period. Side effects such as pain, swelling or bruising at injection site, skin rashes, skin infection hinder growth of the market. Development of products with advanced technologies for facial aesthetic procedures boost demand for facial aesthetics and provide growth opportunities for the facial aesthetics market. For instance, Galderma is a dermatology and pharmaceutical company, which received approval for two products. In May 2020, it received Food & Drug Administration (FDA) approval for restylane kysse, a new hyaluronic acid (ha) filler specifically designed and indicated to add fullness to lips and help smoothen wrinkles above the mouth.
The global facial aesthetics market is segmented on the basis of product, application, end user and region. The product segment is further classified into dermal fillers, botulinum toxin, microdermabrasion, chemical peels and others. On the basis of application, it is segmented into facial line correction treatment, scar treatment, lip enhancement, restoration of volume/ fullness and others.
On the basis end user, the market is categorized into specialty & dermatology clinics, hospitals and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global facial aesthetics market include AbbVie, Anika Therapeutics, Inc., Bausch Health Companies Inc., Candela Syneron, Cutera, Inc., Cynosure, Elan aesthetics, Evolus Inc., Fotona D.O.O, Galderma Laboratories, Ipsen, Johnson and Johnson, Merz Pharma, Revance Therapeutics, Sinclair Pharma, Teoxane, and Vital Esthetique.
The facial aesthetics market is driven by rise in shift of customers toward minimally invasive and non-invasive procedures, increase in number of non-surgical aesthetic procedures such as facial contouring, Botox, injections, facial fillers and other, rise in awareness regarding skin health, and surge in expenditure on human healthcare services boosts growth of the market. According to a report by the American society of plastic surgeons (ASPS), in 2020, it was reported that around 16 million cosmetic procedures are conducted, globally. As per the same source, it was also reported that consumers spent approximately $20 billion on facial aesthetics procedures globally for total consumers. Moreover, according to a report shared by American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) in February 2022, total number of surgical and non-surgical procedures was 1.4 million in 2021, and have increased by 40% than 2020.
In addition, rise in number of botulinum toxin procedure which is also known as Botox injection anticipated to fuel the market growth. For instance, according to a report by Statista, published in 2021, botulinum toxin is the highest non-surgical procedure performed worldwide. Approximately 2.6 million botulinum toxin procedures were performed in 2020 across the globe. Moreover, rise in self-awareness among people regarding aesthetic appearance anticipated to propel the growth of facial aesthetics market. However, side effects associated with facial aesthetic procedures and high cost of procedures are anticipated to hinder the market growth during the forecast period. Side effects such as pain, swelling or bruising at injection site, skin rashes, skin infection hinder growth of the market. Development of products with advanced technologies for facial aesthetic procedures boost demand for facial aesthetics and provide growth opportunities for the facial aesthetics market. For instance, Galderma is a dermatology and pharmaceutical company, which received approval for two products. In May 2020, it received Food & Drug Administration (FDA) approval for restylane kysse, a new hyaluronic acid (ha) filler specifically designed and indicated to add fullness to lips and help smoothen wrinkles above the mouth.
The global facial aesthetics market is segmented on the basis of product, application, end user and region. The product segment is further classified into dermal fillers, botulinum toxin, microdermabrasion, chemical peels and others. On the basis of application, it is segmented into facial line correction treatment, scar treatment, lip enhancement, restoration of volume/ fullness and others.
On the basis end user, the market is categorized into specialty & dermatology clinics, hospitals and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global facial aesthetics market include AbbVie, Anika Therapeutics, Inc., Bausch Health Companies Inc., Candela Syneron, Cutera, Inc., Cynosure, Elan aesthetics, Evolus Inc., Fotona D.O.O, Galderma Laboratories, Ipsen, Johnson and Johnson, Merz Pharma, Revance Therapeutics, Sinclair Pharma, Teoxane, and Vital Esthetique.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the facial aesthetics market analysis from 2021 to 2031 to identify the prevailing facial aesthetics market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the facial aesthetics market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global facial aesthetics market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Dermal fillers
- Botulinum toxin
- Microdermabrasion
- Chemical peels
- Others
By Application
- Facial line correction treatment
- Scar treatment
- Lip enhancement
- Restoration of volume or Fullness
- Others
By End User
- Specialty and Dermatology Clinics
- Hospitals
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- 'Rest Of Europe '
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest Of Asia Pacific
- LAMEA
- Brazil
- Saudi Arabia
- Colombia
- Rest of LAMEA
Key Market Players
- Abbvie Inc
- merz pharma
- galderma laboratories, l.p.
- Candela Syneron
- Vital Esthetique
- Teoxane
- Johnson and Johnson
- Cynosure
- Bausch Health Companies Inc.
- Sinclair Pharmaceuticals Limited
- ipsen
- Fotona D.O.O
- Elan aesthetics
- Anika Therapeutics, Inc.
- Cutera, Inc.
- Evolus Inc.
- Revance Therapeutics
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: FACIAL AESTHETICS MARKET, BY PRODUCT
CHAPTER 5: FACIAL AESTHETICS MARKET, BY APPLICATION
CHAPTER 6: FACIAL AESTHETICS MARKET, BY END USER
CHAPTER 7: FACIAL AESTHETICS MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, titled, “Facial Aesthetics Market," the facial aesthetics market size was valued at $6.23 billion in 2021, and is estimated to reach $25.76 billion by 2031, growing at a CAGR of 15.5% from 2022 to 2031. Facial aesthetics is a procedure where a person chooses non-invasive aesthetic treatment to change their physical appearance. It is performed for aesthetic purpose rather than medical reason. Facial aesthetics, also known as facial rejuvenation treatment which aims to revitalize the skin and provide youthful and radiant appearance.There are various types of facial aesthetics procedures that women and men can choose to create an image that makes them feel more confident and comfortable with their appearance. There are different products available for facial aesthetics, such as cosmetic implants, chemical peels, dermal fillers, Botulinum toxin and microdermabrasion. The application of facial aesthetic treatment includes scar treatment, wrinkle reduction and face uplift, lip augmentation and facial line correction treatment. Laser skin resurfacing can reduce facial wrinkles, scars, and blemishes. Microdermabrasion treatments is a minimally invasive procedure used to renew overall skin tone and texture. In this treatment minimally abrasive instrument used to gently remove thicker, uneven outer layer, and has many benefits.
Factors that drive the growth of the facial aesthetics market trends include rise in geriatric population, increase in number of licensed medical centers to conduct facial aesthetic procedure, technological advancement in the medical aesthetic industry, and increase in the number of product launches by different key players. Moreover, acceptance and adoption of facial aesthetics is more in female population; therefore, increase in female population is anticipated to drive the facial aesthetics market growth.The non-invasive facial aesthetic procedures are highly popular among women due to increased levels of self-consciousness and a desire to be beautiful. For instance, according to a report shared by countrymeters, in 2022, global female population is 3,961,117,370. Moreover, according to data shared by woldometer, in 2022, the U.S. female population is 334,818,770.
Increase in number of approvals for aesthetic products boosts the market growth. For instance, in February 2022, Merz Aesthetics, a medical aesthetics company announced the launch of Radiesse (+) Lidocaine injectable implant for deep injection to improve moderate to severe loss of jawline contour in adults over the age of 21 years. Increase in number of licensed medical centers fuels the growth of facial aesthetics market. The reason behind increasing number of medical centers is attributed to increase in number of non-invasive procedures such as hydra-facial, laser toning, carbon laser peel, injectable skin boosters, chemical peel, dermal fillers and botox. Increase in skin damage and changes in lifestyle are the major factors that lead to rise in number of medical spas. Moreover, rise in self-awareness among young population regarding the physical appearance and increase in awareness regarding different facial aesthetic treatments among the female population are anticipated to propel the growth of facial aesthetics market.
The facial aesthetics market is segmented into product, application, end user and region.On the basis of product, the market is classified into dermal fillers, botulinum toxin, microdermabrasion, chemical peels and others. The dermal fillers segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in adoption of dermal fillers by all age groups and rise in awareness about effectiveness of non-invasive aesthetic procedure among people.
On the basis of application, it is classified into facial line correction treatment, scar treatment, lip enhancement, restoration of volume/fullness and others. The facial line correction treatment segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in geriatric population and rise in number of facial aesthetic procedure.
On the basis of end user, the market is classified into specialty & dermatology clinics, hospitals and others. The hospital segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in number of hospitals and rise in expenditure by governments to improve the healthcare industry.
North America accounted for a majority of the global facial aesthetics market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to rise in number of botulinum toxin procedures, increase in number of approvals for facial aesthetics products, presence of facial aesthetics industry, and advancements in medical and aesthetic sector in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in geriatric populations, rise in awareness among young population regarding aesthetics, growth in healthcare expenditures, and rise in adoption of facial aesthetic products.
Key Findings of the Study
- By product, the dermal fillers segment was the highest contributor to the market in 2021.
- By application, the facial line correction treatment segment was the highest contributor to the market in 2021.
- By end user, the hospital segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
- By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period
Companies Mentioned
- Abbvie Inc
- Merz Pharma
- Galderma Laboratories, L.P.
- Candela Syneron
- Vital Esthetique
- Teoxane
- Johnson and Johnson
- Cynosure
- Bausch Health Companies Inc.
- Sinclair Pharmaceuticals Limited
- Ipsen
- Fotona D.O.O
- Elan Aesthetics
- Anika Therapeutics, Inc.
- Cutera, Inc.
- Evolus Inc.
- Revance Therapeutics
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 279 |
| Published | July 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 6234.5 million |
| Forecasted Market Value ( USD | $ 25764.5 million |
| Compound Annual Growth Rate | 15.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
